Psvity Pharma Private Limited
About Psvity Pharma Private Limited
Data last updated:
Psvity Pharma Private Limited is a private limited company based in Patna, Bihar, India. It was incorporated on 18 November 2023.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U32909BR2023PTC066212.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Kumar Singh and Prerna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Patna, Bihar.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.96 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1,470 (net margin 0.1%) and EBITDA of ₹1,990 (EBITDA margin 0.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Psvity Pharma Private Limited's registered office is in Patna, Bihar.
- Registered AddressC/O Rita Devi W/O Mritunjay Narayan Pratihast, Rajeev Nagar Road No 14 Ward No 06, Patna, Bihar, India – 800024
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Psvity Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Psvity Pharma Private Limited, buy the company report.
Financials of Psvity Pharma Private Limited
FY 2025 filings availablePsvity Pharma Private Limited reported revenue of ₹17.96 Lakh (up 401% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 401% in the latest year. EBITDA rose 96% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1,990 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹1,470 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.1% | |
| Net Profit Margin | 0.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Psvity Pharma Private Limited, buy the company report.
Board of directors of Psvity Pharma Private Limited
Psvity Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar Singh | Director | 18 Nov 2023 | 2 Years 11 Months | Current |
| Prerna | Director | 18 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Psvity Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Debarati Sen Roy (OPC) Private Limited | ₹17.97 Lakh (FY 2025) | 8.0% | Kokata, West Bengal, India | |||
| Phoornav Life Science Private Limited | ₹17.96 Lakh (FY 2024) | 35.0% | Sathyamangalam, Tamil Nadu, India | |||
| Coral Perfumes Private Limited | ₹17.96 Lakh (FY 2024) | 199.0% | Mavelikkara, Kerala, India | |||
| Sri Vidya Consultancy Services Private Limited | ₹17.96 Lakh (FY 2025) | 86.0% | Chennai, Tamil Nadu, India | |||
| Yebelo Technology Private Limited | ₹17.96 Lakh (FY 2025) | -39.0% | Bangalore, Karnataka, India | |||
| Psvity Pharma Private Limitedthis company | ₹17.96 Lakh (FY 2025) | ₹1,470 | 0.1% | 401.0% | Patna, Bihar, India | |
| Ritu the Art Jewellery Private Limited | ₹17.95 Lakh (FY 2022) | 324.0% | Ghaziabad, Uttar Pradesh, India | |||
| Naino IT Solution Private Limited | ₹17.95 Lakh (FY 2025) | 50.0% | Samastipur, Bihar, India | |||
| Unis Green Infra Private Limited | ₹17.95 Lakh (FY 2024) | 66.0% | Jhansi, Uttar Pradesh, India | |||
| RRB Unisex Salon Private Limited | ₹17.95 Lakh (FY 2023) | Gorakhpur, Uttar Pradesh, India | ||||
| Abyla Healthcare Private Limited | ₹17.95 Lakh (FY 2025) | -1.0% | New Delhi, Delhi, India |
To see the full peer comparison of Psvity Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Psvity Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Psvity Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Psvity Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Psvity Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Prerna was appointed as Director on 18 Nov 2023.
Frequently asked questions
Psvity Pharma is an active private limited company based in Patna, Bihar, India. It was incorporated on 18 November 2023 (3+ years old) and is registered under CIN U32909BR2023PTC066212.
Psvity Pharma has 2 current directors:
- Santosh Kumar Singh - Director
- Prerna - Director
The latest financial statements of Psvity Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Psvity Pharma is U32909BR2023PTC066212. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Psvity Pharma was incorporated on 18 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Psvity Pharma by revenue are Debarati Sen Roy (OPC) Private Limited, Phoornav Life Science Private Limited, Coral Perfumes Private Limited, Sri Vidya Consultancy Services Private Limited, Yebelo Technology Private Limited and 5 more, all in the same principal business activity (retail trading).
Prerna was appointed as Director on 18 Nov 2023. Santosh Kumar Singh was appointed as Director on 18 Nov 2023.
The registered office of Psvity Pharma is at CO Rita Devi WO Mritunjay Narayan Pratihast, Rajeev Nagar Road No 14 Ward No 06, Patna, Bihar, India – 800024.
The compliance status of Psvity Pharma is compliant as of 29 September 2026. The company is actively filing with the Registrar of Companies.
Psvity Pharma can be reached at its registered office: CO Rita Devi WO Mritunjay Narayan Pratihast, Rajeev Nagar Road No 14 Ward No 06, Patna, Bihar, India – 800024.
Psvity Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Patna.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
